For the evaluation of ALK and ROS1 gene rearrangements, IHC/ICC was employed in the vast majority of cases (n = 152, 91.0%), whereas RNA-based NGS analysis was adopted in only n = 15 (9.0%) instances. This evidence concerns the gene ALK and intrahepatic cholangiocarcinoma.